Cargando…
A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial
Patients with multiple myeloma are generally older and vary in fitness levels, which may influence the clinical benefit of treatment. Patients from the large, phase 3 FIRST trial in newly diagnosed multiple myeloma (NDMM) were retrospectively investigated to determine outcomes based on frailty using...
Autores principales: | Facon, Thierry, Dimopoulos, Meletios A., Meuleman, Nathalie, Belch, Andrew, Mohty, Mohamad, Chen, Wen-Ming, Kim, Kihyun, Zamagni, Elena, Rodriguez-Otero, Paula, Renwick, William, Rose, Christian, Tempescul, Adrian, Boyle, Eileen, Manier, Salomon, Attal, Michel, Moreau, Philippe, Macro, Margaret, Leleu, Xavier, Lorraine Chretien, Marie, Ludwig, Heinz, Guo, Shien, Sturniolo, Michael, Tinel, Antoine, Silvia Monzini, Mara, Costa, Bruno, Houck, Vanessa, Hulin, Cyrille, Yves Mary, Jean |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214253/ https://www.ncbi.nlm.nih.gov/pubmed/31427722 http://dx.doi.org/10.1038/s41375-019-0539-0 |
Ejemplares similares
-
All-oral triplet combination of ixazomib, lenalidomide, and dexamethasone in newly diagnosed transplant-eligible multiple myeloma patients: final results of the phase II IFM 2013-06 study
por: Touzeau, Cyrille, et al.
Publicado: (2022) -
A predictive model for risk of early grade ≥ 3 infection in patients with multiple myeloma not eligible for transplant: analysis of the FIRST trial
por: Dumontet, Charles, et al.
Publicado: (2018) -
Treatment Regimens for Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: A Systematic Literature Review and Network Meta-analysis
por: Facon, Thierry, et al.
Publicado: (2022) -
Correction to: Treatment Regimens for Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: A Systematic Literature Review and Network Meta-analysis
por: Facon, Thierry, et al.
Publicado: (2022) -
Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: frailty subgroup analysis of MAIA
por: Facon, Thierry, et al.
Publicado: (2022)